Umirolimus – 1 mg

Brand:
Cayman
CAS:
851536-75-9
Storage:
-20
UN-No:
Non-Hazardous - /

Umirolimus is a semi-synthetic macrocyclic lactone and a derivative of rapamycin (Item No. 13346) that has immunosuppressive and anti-inflammatory effects.{36314} It halts the cell cycle at the G1 phase through an IL-2/mTOR-mediated pathway and inhibits proliferation of human smooth muscle cells. In a porcine overstretch model, coronary stents containing umirolimus for localized delivery to the vessel wall reduced stenosis by 50% and led to less thickening of the vessel wall than a bare metal stent. Rapamycin, and likely its derivatives, binds to the cytosolic FK-binding protein 12 (FKBP12) to inhibit the mammalian target of rapamycin (mTOR) pathway. Formulations containing umirolimus have been used in coronary stents for localized delivery to the vessel wall.  

 

Available on backorder

SKU: 23585 - 1 mg Category:

Description

A rapamycin derivative; has immunosuppressive and anti-inflammatory effects; halts the cell cycle at the G1 phase; inhibits proliferation of human smooth muscle cells; reduces stenosis in a porcine overstretch model by 50% when administered as part of the polymer coating of a coronary stent


Formal name: 42-O-(2-ethoxyethyl)-rapamycin

Synonyms: 

Molecular weight: 986.3

CAS: 851536-75-9

Purity: ≥95%

Formulation: A solid


Product Type|Biochemicals||Research Area|Cardiovascular System|Cardiovascular Diseases|Atherosclerosis